Decibel Therapeutics

decibeltx.com
1325 Boylston St, Suite 500
Boston, MA 2215

Company Info

Phone
(617) 370-8701

Year Established
2013

Ticker
REGN

Exchange
NASDAQ

Contacts

Laurence Reid, Ph.D.
President & CEO

Elaine Cope, MBA
VP, Operations

John Lee
CDO

Geoff Horwitz, Ph.D.
VP, Corporate Development

Bridget Cleff, MBA
VP, New Product Planning & Corporate Strategy

Company Description

Decibel Therapeutics, a Regeneron Pharmaceuticals company, is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, one of the largest areas of unmet need in medicine.

Transfection Has Never Been So Easy With Avalanche® Transfection Reagents for Cancer Cells, Primary Cells, And Other Difficult-To-Transfect Cells.Primary Cells, And Other Difficult-To-Transfect Cells.